Keyphrases
T Cells
100%
Cell Activation
100%
Antiretroviral Therapy
100%
AIDS/HIV
100%
Controller
100%
Immune Exhaustion
100%
Exhaustion Marker
100%
Residual Viremia
33%
Quality of Life
22%
HLA-DR
22%
T Cell Activation
22%
CD4+
22%
CD8+ T Cells
22%
Virus RNA
22%
CD38
22%
Inflammation
11%
Viral Replication
11%
Human Immunodeficiency Virus Type 1 (HIV-1)
11%
Tenofovir Disoproxil Fumarate
11%
Virus DNA
11%
Immune Activation
11%
Generalized Estimating Equations
11%
Equation Model
11%
Virus Interference
11%
Clinical Benefit
11%
Antiretroviral Naïve
11%
Cell Markers
11%
Antiretroviral Therapy Initiation
11%
RNA Copies
11%
Integrase
11%
Residual Plasma
11%
Plasma Viremia
11%
Single-copy Assay
11%
Rilpivirine
11%
Self-reported Quality of Life
11%
EQ-5D Questionnaire
11%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
T Lymphocyte Activation
100%
Viremia
44%
Ribonucleic Acid
33%
Blood Plasma
22%
HLA-DR
22%
T Cell Activation
22%
Cytotoxic T-Cell
22%
CD4 Lymphocyte Count
22%
CD38
22%
Viral Replication
11%
Human Immunodeficiency Virus 1
11%
Cell Marker
11%
Integrase
11%
Tenofovir
11%
DNA Virus
11%
Neuroscience
Human Immunodeficiency Virus
100%
Cell Activation
100%
T Cell
40%
Quality of Life
30%
CD4
20%
CD8
20%
HLA-DR
20%
CD38
20%
Blood Plasma
20%
DNA Virus
10%
Tenofovir Disoproxil
10%
Integrase
10%
Rilpivirine
10%
Emtricitabine
10%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Viremia
44%
Virus RNA
22%
CD8 Antigen
22%
Inflammation
11%
Tenofovir Disoproxil
11%
Emtricitabine
11%
Cell Marker
11%
Virus DNA
11%
Human Immunodeficiency Virus 1
11%
Rilpivirine
11%
Integrase
11%